These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 5158186)
1. [Avoidance of transfusion reactions by the use of largely leukocyte- and thrombocyte-free erythrocyte extracts]. Marcard E; Spiess HG Bibl Haematol; 1971; 37():194-8. PubMed ID: 5158186 [No Abstract] [Full Text] [Related]
2. Interdisciplinary session report. Obstacles to routine transfusion support of myelosuppressive patients. Henderson ES; Graw RG; Anderson RM; Yankee RA; Opelz G; Lalezari P; Meryman HT Cancer Chemother Rep 3; 1973 May; 4(3):51-9. PubMed ID: 4748873 [No Abstract] [Full Text] [Related]
3. [Indications of blood cell and platelet concentrates]. Chataing B; Revol L Rev Prat; 1972 Mar; 22(9):1453-4 passim. PubMed ID: 4647335 [No Abstract] [Full Text] [Related]
4. [Allo-immunisation against leucocyte, thrombocyte and tissue antigens caused by transfusion (author's transl)]. Heiss F; Goldmann SF; Scheinert I Munch Med Wochenschr; 1973 Nov; 115(44):1974-8. PubMed ID: 4801764 [No Abstract] [Full Text] [Related]
5. [Advances in platelet transfusion]. Kummer H Ther Umsch; 1973 Nov; 30(11):797-801. PubMed ID: 4585652 [No Abstract] [Full Text] [Related]
6. [Targetted hemotherapy with special reference to the cellular components]. Dörner R Dtsch Med Wochenschr; 1990 Jul; 115(27):1066-72. PubMed ID: 2194776 [No Abstract] [Full Text] [Related]
7. [Formation of anti-leukocyte antibody and anti-platelet antibody and its effects on blood component transfusion]. Shimoyama M; Minato K; Ideura Y; Kimura K Nihon Rinsho; 1977 Dec; 35(12):4146-54. PubMed ID: 342757 [No Abstract] [Full Text] [Related]
8. [Anti-leukocyte and anti-platelet immunization and transfusions during aplastic anemias]. Dausset J; Benbunan M Nouv Rev Fr Hematol (1978); 1976 Jun; 16(1):132-43. PubMed ID: 781619 [No Abstract] [Full Text] [Related]
9. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components. Eernisse JG; Brand A Exp Hematol; 1981 Jan; 9(1):77-83. PubMed ID: 7238644 [TBL] [Abstract][Full Text] [Related]
10. Alloimmunization by leukocyte-rich or leukocyte-poor random single donor platelets. Gmür J; Burger J; Sauter C; Oelz O; Frick PG Prog Clin Biol Res; 1990; 337():45-8. PubMed ID: 2191337 [No Abstract] [Full Text] [Related]
11. [Complications in blood transfusion]. Höglund S Lakartidningen; 1972 Dec; 69():Suppl 4:65-72. PubMed ID: 4656852 [No Abstract] [Full Text] [Related]
12. [Leukocyte and thrombocyte-poorly filtered blood]. Langfelder M; Zsdanszky L Bibl Haematol; 1967; 27():284-8. PubMed ID: 5595095 [No Abstract] [Full Text] [Related]
13. [Complications in the transfusion of blood and its derivatives]. Kazakova LM; Malakhovskiĭ IuE Pediatriia; 1980; (9):62-4. PubMed ID: 7001339 [No Abstract] [Full Text] [Related]
14. Principles of hematologic supportive care. Graw RG; Yankee RA Med Clin North Am; 1973 Mar; 57(2):441-61. PubMed ID: 4570935 [No Abstract] [Full Text] [Related]
16. [Use of thrombocyte transfusion in clinical practice]. Krstić C; Radojicić B Vojnosanit Pregl; 1975; 32(4):409-11. PubMed ID: 1162935 [No Abstract] [Full Text] [Related]
17. Effect of splenectomy on the response to platelet transfusion in three patients with aplastic anemia. Flatow FA; Freireich EJ N Engl J Med; 1966 Feb; 274(5):242-8. PubMed ID: 5216246 [No Abstract] [Full Text] [Related]